nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—PTGS1—Etoposide—sarcoma	0.126	0.197	CbGbCtD
Terbinafine—CYP1A2—Dacarbazine—sarcoma	0.115	0.18	CbGbCtD
Terbinafine—CYP3A4—Thiotepa—sarcoma	0.109	0.17	CbGbCtD
Terbinafine—CYP2C8—Etoposide—sarcoma	0.0727	0.114	CbGbCtD
Terbinafine—CYP1A2—Etoposide—sarcoma	0.0562	0.0881	CbGbCtD
Terbinafine—CYP3A4—Mitoxantrone—sarcoma	0.0467	0.0732	CbGbCtD
Terbinafine—CYP3A4—Vincristine—sarcoma	0.0322	0.0504	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—sarcoma	0.0316	0.0495	CbGbCtD
Terbinafine—CYP3A4—Etoposide—sarcoma	0.0295	0.0462	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—sarcoma	0.0201	0.0315	CbGbCtD
Terbinafine—SQLE—uterus—sarcoma	0.00109	0.0595	CbGeAlD
Terbinafine—SQLE—tendon—sarcoma	0.000951	0.0521	CbGeAlD
Terbinafine—CYP11A1—hematopoietic system—sarcoma	0.000942	0.0516	CbGeAlD
Terbinafine—CYP11A1—connective tissue—sarcoma	0.000907	0.0497	CbGeAlD
Terbinafine—SQLE—testis—sarcoma	0.000787	0.0431	CbGeAlD
Terbinafine—Anorexia—Mitoxantrone—sarcoma	0.000746	0.00217	CcSEcCtD
Terbinafine—SQLE—liver—sarcoma	0.000744	0.0408	CbGeAlD
Terbinafine—Feeling abnormal—Dactinomycin—sarcoma	0.000742	0.00216	CcSEcCtD
Terbinafine—Gastrointestinal pain—Thiotepa—sarcoma	0.000741	0.00216	CcSEcCtD
Terbinafine—Ill-defined disorder—Etoposide—sarcoma	0.00074	0.00216	CcSEcCtD
Terbinafine—Anaemia—Etoposide—sarcoma	0.000738	0.00215	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000736	0.00214	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000733	0.00213	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000728	0.00212	CcSEcCtD
Terbinafine—PTGS1—endothelium—sarcoma	0.000723	0.0396	CbGeAlD
Terbinafine—Paraesthesia—Vincristine—sarcoma	0.000722	0.0021	CcSEcCtD
Terbinafine—Urticaria—Thiotepa—sarcoma	0.00072	0.0021	CcSEcCtD
Terbinafine—Malaise—Etoposide—sarcoma	0.00072	0.0021	CcSEcCtD
Terbinafine—Dermatitis bullous—Doxorubicin—sarcoma	0.000719	0.0021	CcSEcCtD
Terbinafine—CYP2C8—mammary gland—sarcoma	0.000719	0.0394	CbGeAlD
Terbinafine—Vertigo—Etoposide—sarcoma	0.000717	0.00209	CcSEcCtD
Terbinafine—Abdominal pain—Thiotepa—sarcoma	0.000717	0.00209	CcSEcCtD
Terbinafine—Body temperature increased—Thiotepa—sarcoma	0.000717	0.00209	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000713	0.00208	CcSEcCtD
Terbinafine—Body temperature increased—Dactinomycin—sarcoma	0.000711	0.00207	CcSEcCtD
Terbinafine—Abdominal pain—Dactinomycin—sarcoma	0.000711	0.00207	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00071	0.00207	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—sarcoma	0.000704	0.00205	CcSEcCtD
Terbinafine—Paraesthesia—Mitoxantrone—sarcoma	0.000703	0.00205	CcSEcCtD
Terbinafine—Decreased appetite—Vincristine—sarcoma	0.000699	0.00204	CcSEcCtD
Terbinafine—Cough—Etoposide—sarcoma	0.000696	0.00203	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Vincristine—sarcoma	0.000694	0.00202	CcSEcCtD
Terbinafine—Fatigue—Vincristine—sarcoma	0.000693	0.00202	CcSEcCtD
Terbinafine—Dyspepsia—Mitoxantrone—sarcoma	0.000689	0.00201	CcSEcCtD
Terbinafine—Pain—Vincristine—sarcoma	0.000688	0.002	CcSEcCtD
Terbinafine—Decreased appetite—Mitoxantrone—sarcoma	0.000681	0.00198	CcSEcCtD
Terbinafine—Chest pain—Etoposide—sarcoma	0.000679	0.00198	CcSEcCtD
Terbinafine—Abdominal pain upper—Epirubicin—sarcoma	0.000678	0.00198	CcSEcCtD
Terbinafine—Fatigue—Mitoxantrone—sarcoma	0.000675	0.00197	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000675	0.00197	CcSEcCtD
Terbinafine—Discomfort—Etoposide—sarcoma	0.000671	0.00196	CcSEcCtD
Terbinafine—Pain—Mitoxantrone—sarcoma	0.00067	0.00195	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000669	0.00195	CcSEcCtD
Terbinafine—Hypersensitivity—Thiotepa—sarcoma	0.000668	0.00195	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—sarcoma	0.000664	0.00194	CcSEcCtD
Terbinafine—Hypersensitivity—Dactinomycin—sarcoma	0.000663	0.00193	CcSEcCtD
Terbinafine—Gastrointestinal pain—Vincristine—sarcoma	0.000657	0.00192	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—sarcoma	0.000657	0.00192	CcSEcCtD
Terbinafine—Confusional state—Etoposide—sarcoma	0.000657	0.00191	CcSEcCtD
Terbinafine—Anaphylactic shock—Etoposide—sarcoma	0.000651	0.0019	CcSEcCtD
Terbinafine—Asthenia—Thiotepa—sarcoma	0.000651	0.0019	CcSEcCtD
Terbinafine—Infection—Etoposide—sarcoma	0.000647	0.00189	CcSEcCtD
Terbinafine—Asthenia—Dactinomycin—sarcoma	0.000646	0.00188	CcSEcCtD
Terbinafine—Feeling abnormal—Mitoxantrone—sarcoma	0.000645	0.00188	CcSEcCtD
Terbinafine—Influenza—Epirubicin—sarcoma	0.000642	0.00187	CcSEcCtD
Terbinafine—Pruritus—Thiotepa—sarcoma	0.000641	0.00187	CcSEcCtD
Terbinafine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00064	0.00187	CcSEcCtD
Terbinafine—CYP2C9—mammary gland—sarcoma	0.000639	0.035	CbGeAlD
Terbinafine—Thrombocytopenia—Etoposide—sarcoma	0.000638	0.00186	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—sarcoma	0.000636	0.00185	CcSEcCtD
Terbinafine—Body temperature increased—Vincristine—sarcoma	0.000636	0.00185	CcSEcCtD
Terbinafine—Abdominal pain—Vincristine—sarcoma	0.000636	0.00185	CcSEcCtD
Terbinafine—Skin disorder—Etoposide—sarcoma	0.000633	0.00184	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—sarcoma	0.000629	0.00183	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—sarcoma	0.000628	0.00183	CcSEcCtD
Terbinafine—Urticaria—Mitoxantrone—sarcoma	0.000622	0.00181	CcSEcCtD
Terbinafine—Anorexia—Etoposide—sarcoma	0.000621	0.00181	CcSEcCtD
Terbinafine—Diarrhoea—Thiotepa—sarcoma	0.00062	0.00181	CcSEcCtD
Terbinafine—Abdominal pain—Mitoxantrone—sarcoma	0.000619	0.0018	CcSEcCtD
Terbinafine—Body temperature increased—Mitoxantrone—sarcoma	0.000619	0.0018	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000619	0.0018	CcSEcCtD
Terbinafine—Diarrhoea—Dactinomycin—sarcoma	0.000616	0.00179	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—sarcoma	0.000615	0.00179	CcSEcCtD
Terbinafine—CYP19A1—hematopoietic system—sarcoma	0.000612	0.0335	CbGeAlD
Terbinafine—Pancytopenia—Epirubicin—sarcoma	0.00061	0.00178	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—sarcoma	0.000608	0.00177	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—sarcoma	0.0006	0.00175	CcSEcCtD
Terbinafine—Dizziness—Thiotepa—sarcoma	0.0006	0.00175	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000597	0.00174	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—sarcoma	0.000594	0.00173	CcSEcCtD
Terbinafine—Hypersensitivity—Vincristine—sarcoma	0.000592	0.00173	CcSEcCtD
Terbinafine—CYP19A1—connective tissue—sarcoma	0.000589	0.0323	CbGeAlD
Terbinafine—Eosinophilia—Doxorubicin—sarcoma	0.000588	0.00171	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—sarcoma	0.000586	0.00171	CcSEcCtD
Terbinafine—Paraesthesia—Etoposide—sarcoma	0.000585	0.0017	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—sarcoma	0.000582	0.0017	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—sarcoma	0.000581	0.00169	CcSEcCtD
Terbinafine—Hypersensitivity—Mitoxantrone—sarcoma	0.000577	0.00168	CcSEcCtD
Terbinafine—Asthenia—Vincristine—sarcoma	0.000577	0.00168	CcSEcCtD
Terbinafine—Vomiting—Thiotepa—sarcoma	0.000576	0.00168	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—sarcoma	0.000572	0.00167	CcSEcCtD
Terbinafine—Infestation—Epirubicin—sarcoma	0.000572	0.00167	CcSEcCtD
Terbinafine—Vomiting—Dactinomycin—sarcoma	0.000572	0.00167	CcSEcCtD
Terbinafine—Rash—Thiotepa—sarcoma	0.000572	0.00167	CcSEcCtD
Terbinafine—Dermatitis—Thiotepa—sarcoma	0.000571	0.00166	CcSEcCtD
Terbinafine—SQLE—lymph node—sarcoma	0.000571	0.0313	CbGeAlD
Terbinafine—Headache—Thiotepa—sarcoma	0.000568	0.00165	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000568	0.00165	CcSEcCtD
Terbinafine—Rash—Dactinomycin—sarcoma	0.000567	0.00165	CcSEcCtD
Terbinafine—Decreased appetite—Etoposide—sarcoma	0.000566	0.00165	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—sarcoma	0.000564	0.00164	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Etoposide—sarcoma	0.000562	0.00164	CcSEcCtD
Terbinafine—Asthenia—Mitoxantrone—sarcoma	0.000562	0.00164	CcSEcCtD
Terbinafine—Fatigue—Etoposide—sarcoma	0.000562	0.00164	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—sarcoma	0.000558	0.00163	CcSEcCtD
Terbinafine—Pain—Etoposide—sarcoma	0.000557	0.00162	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—sarcoma	0.000555	0.00162	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000552	0.00161	CcSEcCtD
Terbinafine—Diarrhoea—Vincristine—sarcoma	0.00055	0.0016	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000542	0.00158	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—sarcoma	0.000541	0.00158	CcSEcCtD
Terbinafine—Nausea—Thiotepa—sarcoma	0.000539	0.00157	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—sarcoma	0.000537	0.00157	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—sarcoma	0.000537	0.00156	CcSEcCtD
Terbinafine—Diarrhoea—Mitoxantrone—sarcoma	0.000536	0.00156	CcSEcCtD
Terbinafine—Nausea—Dactinomycin—sarcoma	0.000535	0.00156	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—sarcoma	0.000534	0.00156	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—sarcoma	0.000533	0.00155	CcSEcCtD
Terbinafine—Dizziness—Vincristine—sarcoma	0.000532	0.00155	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—sarcoma	0.00053	0.00154	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—sarcoma	0.00053	0.00154	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000525	0.00153	CcSEcCtD
Terbinafine—Urticaria—Etoposide—sarcoma	0.000517	0.00151	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—sarcoma	0.000516	0.0015	CcSEcCtD
Terbinafine—CYP11A1—testis—sarcoma	0.000516	0.0283	CbGeAlD
Terbinafine—Abdominal pain—Etoposide—sarcoma	0.000515	0.0015	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—sarcoma	0.000515	0.0015	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—sarcoma	0.000514	0.0015	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—sarcoma	0.000511	0.00149	CcSEcCtD
Terbinafine—Vomiting—Vincristine—sarcoma	0.000511	0.00149	CcSEcCtD
Terbinafine—Rash—Vincristine—sarcoma	0.000507	0.00148	CcSEcCtD
Terbinafine—Dermatitis—Vincristine—sarcoma	0.000506	0.00148	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—sarcoma	0.000505	0.00147	CcSEcCtD
Terbinafine—Headache—Vincristine—sarcoma	0.000504	0.00147	CcSEcCtD
Terbinafine—CYP2C19—hematopoietic system—sarcoma	0.000502	0.0275	CbGeAlD
Terbinafine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000501	0.00146	CcSEcCtD
Terbinafine—Vomiting—Mitoxantrone—sarcoma	0.000498	0.00145	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—sarcoma	0.000495	0.00144	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—sarcoma	0.000494	0.00144	CcSEcCtD
Terbinafine—Rash—Mitoxantrone—sarcoma	0.000494	0.00144	CcSEcCtD
Terbinafine—Dermatitis—Mitoxantrone—sarcoma	0.000493	0.00144	CcSEcCtD
Terbinafine—Headache—Mitoxantrone—sarcoma	0.000491	0.00143	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—sarcoma	0.000486	0.00142	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—sarcoma	0.00048	0.0014	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—sarcoma	0.00048	0.0014	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—sarcoma	0.000479	0.0014	CcSEcCtD
Terbinafine—Nausea—Vincristine—sarcoma	0.000478	0.00139	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—sarcoma	0.000475	0.00139	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—sarcoma	0.000473	0.00138	CcSEcCtD
Terbinafine—Asthenia—Etoposide—sarcoma	0.000467	0.00136	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—sarcoma	0.000467	0.00136	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—sarcoma	0.000466	0.00136	CcSEcCtD
Terbinafine—Nausea—Mitoxantrone—sarcoma	0.000465	0.00136	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—sarcoma	0.000464	0.00135	CcSEcCtD
Terbinafine—CYP19A1—uterus—sarcoma	0.000462	0.0253	CbGeAlD
Terbinafine—Pruritus—Etoposide—sarcoma	0.000461	0.00134	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—sarcoma	0.000458	0.00134	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—sarcoma	0.000454	0.00132	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—sarcoma	0.00045	0.00131	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—sarcoma	0.00045	0.00131	CcSEcCtD
Terbinafine—Erythema—Epirubicin—sarcoma	0.000447	0.0013	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—sarcoma	0.000446	0.0013	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—sarcoma	0.000444	0.00129	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—sarcoma	0.000443	0.00129	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—sarcoma	0.000441	0.00128	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—sarcoma	0.000438	0.00128	CcSEcCtD
Terbinafine—CYP2C8—hematopoietic system—sarcoma	0.000438	0.024	CbGeAlD
Terbinafine—Angiopathy—Doxorubicin—sarcoma	0.000431	0.00126	CcSEcCtD
Terbinafine—Dizziness—Etoposide—sarcoma	0.000431	0.00125	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—sarcoma	0.00043	0.00125	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—sarcoma	0.000429	0.00125	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—sarcoma	0.000422	0.00123	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—sarcoma	0.00042	0.00122	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—sarcoma	0.000417	0.00121	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—sarcoma	0.000415	0.00121	CcSEcCtD
Terbinafine—Vomiting—Etoposide—sarcoma	0.000414	0.00121	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—sarcoma	0.000414	0.00121	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—sarcoma	0.000413	0.0012	CcSEcCtD
Terbinafine—Rash—Etoposide—sarcoma	0.000411	0.0012	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—sarcoma	0.00041	0.0012	CcSEcCtD
Terbinafine—CYP1A2—hematopoietic system—sarcoma	0.00041	0.0225	CbGeAlD
Terbinafine—Headache—Etoposide—sarcoma	0.000408	0.00119	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—sarcoma	0.000408	0.00119	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—sarcoma	0.000405	0.00118	CcSEcCtD
Terbinafine—Malaise—Epirubicin—sarcoma	0.000403	0.00118	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—sarcoma	0.000402	0.00117	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—sarcoma	0.000398	0.00116	CcSEcCtD
Terbinafine—Cough—Epirubicin—sarcoma	0.00039	0.00114	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—sarcoma	0.00039	0.00114	CcSEcCtD
Terbinafine—CYP2C9—hematopoietic system—sarcoma	0.000389	0.0213	CbGeAlD
Terbinafine—Nausea—Etoposide—sarcoma	0.000387	0.00113	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—sarcoma	0.000384	0.00112	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—sarcoma	0.000383	0.00111	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—sarcoma	0.000381	0.00111	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—sarcoma	0.000381	0.00111	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—sarcoma	0.000381	0.00111	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—sarcoma	0.00038	0.00111	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000378	0.0011	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—sarcoma	0.000376	0.0011	CcSEcCtD
Terbinafine—CYP11A1—lymph node—sarcoma	0.000374	0.0205	CbGeAlD
Terbinafine—PTGS1—seminal vesicle—sarcoma	0.000374	0.0205	CbGeAlD
Terbinafine—Malaise—Doxorubicin—sarcoma	0.000373	0.00109	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—sarcoma	0.000372	0.00109	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—sarcoma	0.000372	0.00108	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—sarcoma	0.000368	0.00107	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—sarcoma	0.000365	0.00106	CcSEcCtD
Terbinafine—Infection—Epirubicin—sarcoma	0.000363	0.00106	CcSEcCtD
Terbinafine—Cough—Doxorubicin—sarcoma	0.000361	0.00105	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—sarcoma	0.000358	0.00104	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—sarcoma	0.000357	0.00104	CcSEcCtD
Terbinafine—PTGS1—hematopoietic system—sarcoma	0.000355	0.0195	CbGeAlD
Terbinafine—Skin disorder—Epirubicin—sarcoma	0.000355	0.00103	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—sarcoma	0.000352	0.00103	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—sarcoma	0.000352	0.00103	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—sarcoma	0.000352	0.00103	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—sarcoma	0.000351	0.00102	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00035	0.00102	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—sarcoma	0.000348	0.00101	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—sarcoma	0.000348	0.00101	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—sarcoma	0.000345	0.001	CcSEcCtD
Terbinafine—PTGS1—connective tissue—sarcoma	0.000342	0.0187	CbGeAlD
Terbinafine—Confusional state—Doxorubicin—sarcoma	0.000341	0.000992	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—sarcoma	0.000338	0.000984	CcSEcCtD
Terbinafine—Infection—Doxorubicin—sarcoma	0.000336	0.000978	CcSEcCtD
Terbinafine—CYP19A1—testis—sarcoma	0.000335	0.0184	CbGeAlD
Terbinafine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000333	0.000969	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—sarcoma	0.000331	0.000965	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—sarcoma	0.000331	0.000964	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—sarcoma	0.000328	0.000956	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—sarcoma	0.000328	0.000955	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—sarcoma	0.000322	0.000938	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—sarcoma	0.000321	0.000936	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—sarcoma	0.000317	0.000925	CcSEcCtD
Terbinafine—CYP19A1—liver—sarcoma	0.000317	0.0174	CbGeAlD
Terbinafine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000315	0.000918	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—sarcoma	0.000315	0.000917	CcSEcCtD
Terbinafine—PTGS1—smooth muscle tissue—sarcoma	0.000313	0.0171	CbGeAlD
Terbinafine—Pain—Epirubicin—sarcoma	0.000312	0.00091	CcSEcCtD
Terbinafine—PTGS1—skin of body—sarcoma	0.000309	0.0169	CbGeAlD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000308	0.000897	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—sarcoma	0.000303	0.000884	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—sarcoma	0.000301	0.000877	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—sarcoma	0.000299	0.00087	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—sarcoma	0.000297	0.000866	CcSEcCtD
Terbinafine—CYP3A4—hematopoietic system—sarcoma	0.000297	0.0163	CbGeAlD
Terbinafine—Decreased appetite—Doxorubicin—sarcoma	0.000294	0.000856	CcSEcCtD
Terbinafine—CYP2D6—hematopoietic system—sarcoma	0.000292	0.016	CbGeAlD
Terbinafine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000292	0.00085	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—sarcoma	0.000291	0.000849	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—sarcoma	0.00029	0.000845	CcSEcCtD
Terbinafine—Pain—Doxorubicin—sarcoma	0.000289	0.000842	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—sarcoma	0.000289	0.000841	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—sarcoma	0.000289	0.000841	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—sarcoma	0.000278	0.000811	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000276	0.000805	CcSEcCtD
Terbinafine—PTGS1—cardiac atrium—sarcoma	0.00027	0.0148	CbGeAlD
Terbinafine—Hypersensitivity—Epirubicin—sarcoma	0.000269	0.000784	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—sarcoma	0.000268	0.000782	CcSEcCtD
Terbinafine—PTGS1—uterus—sarcoma	0.000268	0.0147	CbGeAlD
Terbinafine—Abdominal pain—Doxorubicin—sarcoma	0.000267	0.000778	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—sarcoma	0.000267	0.000778	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—sarcoma	0.000262	0.000763	CcSEcCtD
Terbinafine—CYP2C19—liver—sarcoma	0.00026	0.0142	CbGeAlD
Terbinafine—Pruritus—Epirubicin—sarcoma	0.000258	0.000753	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—sarcoma	0.00025	0.000728	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—sarcoma	0.000249	0.000725	CcSEcCtD
Terbinafine—CYP19A1—lymph node—sarcoma	0.000243	0.0133	CbGeAlD
Terbinafine—Asthenia—Doxorubicin—sarcoma	0.000242	0.000706	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—sarcoma	0.000241	0.000703	CcSEcCtD
Terbinafine—CYP2C8—testis—sarcoma	0.00024	0.0132	CbGeAlD
Terbinafine—Pruritus—Doxorubicin—sarcoma	0.000239	0.000696	CcSEcCtD
Terbinafine—PTGS1—tendon—sarcoma	0.000235	0.0129	CbGeAlD
Terbinafine—Vomiting—Epirubicin—sarcoma	0.000232	0.000676	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—sarcoma	0.000231	0.000673	CcSEcCtD
Terbinafine—Rash—Epirubicin—sarcoma	0.00023	0.000671	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—sarcoma	0.00023	0.00067	CcSEcCtD
Terbinafine—Headache—Epirubicin—sarcoma	0.000229	0.000666	CcSEcCtD
Terbinafine—CYP2C8—liver—sarcoma	0.000227	0.0124	CbGeAlD
Terbinafine—Dizziness—Doxorubicin—sarcoma	0.000223	0.000651	CcSEcCtD
Terbinafine—Nausea—Epirubicin—sarcoma	0.000217	0.000632	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—sarcoma	0.000215	0.000626	CcSEcCtD
Terbinafine—Rash—Doxorubicin—sarcoma	0.000213	0.000621	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—sarcoma	0.000213	0.00062	CcSEcCtD
Terbinafine—CYP1A2—liver—sarcoma	0.000212	0.0116	CbGeAlD
Terbinafine—Headache—Doxorubicin—sarcoma	0.000212	0.000617	CcSEcCtD
Terbinafine—CYP2C9—liver—sarcoma	0.000202	0.011	CbGeAlD
Terbinafine—Nausea—Doxorubicin—sarcoma	0.000201	0.000585	CcSEcCtD
Terbinafine—PTGS1—testis—sarcoma	0.000195	0.0107	CbGeAlD
Terbinafine—CYP2D6—testis—sarcoma	0.00016	0.00877	CbGeAlD
Terbinafine—CYP3A4—liver—sarcoma	0.000154	0.00842	CbGeAlD
Terbinafine—CYP2D6—liver—sarcoma	0.000151	0.00829	CbGeAlD
Terbinafine—PTGS1—lymph node—sarcoma	0.000141	0.00773	CbGeAlD
